33
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7656 |
Apelin-13
|
||
Apelin-13 是存在于中枢和外周神经系统由13个氨基酸组成的多肽序列,是 G 蛋白偶联受体angiotensin II protein J (APJ) 的内源性配体,对 APJ 的 EC50 值为 0.37 nM。Apelin-13 具有扩张血管和降压活性,可用于研究 2 型糖尿病综合征。 | |||
T6574 |
Lumiracoxib
Prexige,罗美昔布,COX-189 |
COX | Immunology/Inflammation; Neuroscience |
Lumiracoxib (Prexige) 是强选择性有口服活性的 COX-2抑制剂,Ki 值为 0.06 μM。它是非选择性非甾体抗炎试剂,具有抗炎和解热活性,可用于骨关节炎和骨癌研究。 | |||
T5427 |
GSK1940029
SCD inhibitor 1 |
Dehydrogenase; Stearoyl-CoA Desaturase (SCD) | Metabolism |
GSK1940029 (SCD inhibitor 1) 是酰基-辅酶A 去饱和酶 (SCD) 抑制剂。 | |||
T0773 |
Febuxostat
非布索坦,TMX 67,非布司他,TEI 6720 |
ROS; Xanthine Oxidase | Immunology/Inflammation; Metabolism |
Febuxostat (TEI 6720) 是一种选择性黄嘌呤氧化酶(XO)抑制剂,Ki=0.6 nM。 | |||
T14364 |
AZ-Dyrk1B-33
3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine |
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) 是高选择性的Dyrk1B 激酶抑制剂,其IC50=7 nM。 | |||
T77784 |
WAY-297848
|
Glucokinase | Metabolism |
WAY-297848 是一种新型的 glucokinase 激活剂,可用于预防或治疗高血糖、糖尿病、肥胖症、血脂异常和代谢综合征。 | |||
T31992 |
Granotapide
|
CETP | Metabolism |
Granotapide 是一种微粒体甘油三酯转移蛋白(MTP)抑制剂,治疗和而预防动脉硬化,冠状动脉疾病,代谢综合征,肥胖,糖尿病,糖尿病前期和高血压。 | |||
T9089 |
FTO-IN-1
UUN44923 |
Others | Others |
UUN44923 是脂肪及肥胖相关酶(FTO) 抑制剂(IC50<1 μM)。其中FTO-IN-1 (UUN44923) 可用于研究癌症。 | |||
T72814 |
11β-HSD1-IN-12
|
Dehydrogenase | Metabolism |
11β-HSD1-IN-12 是一种11β-HSD1抑制剂。11β-HSD1 可从非活性形式再生活性糖皮质激素,在调节细胞内糖皮质激素浓度方面很重要。11β-HSD1-IN-12 可用于肥胖和代谢综合征的研究。 | |||
T62929 |
RLX-33
|
ERK; RXFP receptor | GPCR/G Protein; MAPK |
RLX-33 是一种有效的、选择性的、能够透过血脑屏障的松弛素家族肽 3 (RXFP3) 拮抗剂,也能够阻断松弛素 3 (relaxin 3) 诱导的 ERK1/2 磷酸化。RLX-33 作用于 RXFP3、ERK1 和 ERK2 磷酸化的 IC50 分别为 2.36 μM、7.82 μM 和 13.86 μM。RLX-33 可以阻断 RXFP3 选择性激动剂 R3/I5 诱导的大鼠食物摄取增加。RLX-33 能够用于研究代谢综合征。 | |||
T27338 |
Fluasterone
HE 2500,HE-2500,HE2500 |
||
Fluasterone, an NF-κB activation inhibitor, is used potentially for the treatment of metabolic syndrome. | |||
T27707 |
K118
K 118,K-118 |
||
K118 is an inhibitor of SH2-containing inositol 5' phosphatase 1 (SHIP1). It reverses diet- and age-associated obesity and metabolic syndrome. | |||
T33423 |
MK-0916
MK 0916 |
||
MK-0916 is a 11β-hydroxysteroid dehydrogenase type 1 inhibitor indicated for the treatment of type 2 diabetes and metabolic syndrome as well as obesity-related diseases. | |||
T10510 |
CB1 antagonist 1
|
Cannabinoid Receptor | GPCR/G Protein |
CB1 antagonist 1 is a CB1 receptor antagonist, used in the research of obesity and metabolic syndrome, neuroinflammatory disorders, cognitive disorders, and gastrointestinal disorders, psychosis, and cardiovascular. | |||
T40675 |
CP-610431
|
||
CP-610431 is a reversible, ATP-uncompetitive inhibitor of acetyl-CoA carboxylase (ACC), exhibiting isozyme nonselectivity. It inhibits both ACC1 and ACC2 with IC50 values of approximately 50 nM. CP-610431 offers potential application in metabolic syndrome research. | |||
T35886 |
L-hydroxy Arginine (acetate)
|
||
L-hydroxy Arginine is a substrate for nitric oxide synthase in the catabolism of L-arginine to form nitric oxide. It has been used as a biomarker for reduced nitric oxide formation in patients with cardiovascular disease and metabolic syndrome. | |||
T70509 |
INU-101
|
||
INU-101 is an 11β-HSD1 inhibitor. In KKAy mice, ob/ob mice, and ZDF rats, oral administration of INU-101 led to enhanced insulin sensitivity and the lowering of the fasting level of glucose in the blood. INU-101 therefore shows promise as a potential treatment for type 2 diabetes and metabolic syndrome. | |||
T80817 |
WAY-328127
|
||
WAY-328127是一种活性分子,适用于生化反应研究。 | |||
T38716 |
SAR247799
SAR247799,S1P1 agonist 3 |
||
SAR247799 (S1P1 agonist 3) is an orally-active, selective G-protein-biased agonist for the sphingosine-1 phosphate receptor-1 (S1P1). It demonstrates EC50 values ranging from 12.6 to 493 nM in S1P1-overexpressing cells and HUVECs. SAR247799 holds promise as a valuable tool for investigating endothelial protection, particularly in the context of type-2 diabetes and metabolic syndrome[4]. | |||
T82952 | ATF3 inducer 1 | ||
ATF3 inducer 1, 作为一种高效ATF3诱导剂,能显著提高ATF3蛋白及其mRNA的表达水平,并在小鼠模型中展现出对MetS的抗性活性。 | |||
T37405 | Octanoyl Coenzyme A (sodium salt) | ||
Octanoyl coenzyme A (octanoyl-CoA) is a medium-chain acyl CoA and a metabolic intermediate in mitochondrial fatty acid β-oxidation. Levels of octanoyl-CoA are increased in the liver of patients with Reye's syndrome and β-oxidation of octanoyl-CoA by medium-chain acyl CoA dehydrogenase (MCADH) is decreased in patients with MCADH deficiency (MCD). Octanoyl-CoA inhibits citrate synthase and glutamate dehydrogenase. | |||
T35790 |
Palmitic acid-1,2,3,4-13C4
Palmitic Acid-13C (C1, C2, C3, and C4 labeled) |
||
Palmitic acid-13C (C1, C2, C3, and C4 labeled) is intended for use as an internal standard for the quantification of palmitic acid by GC- or LC-MS. Palmitic acid is a common 16-carbon saturated fat that represents 10-20% of human dietary fat intake and comprises approximately 25 and 65% of human total plasma lipids and saturated fatty acids, respectively.1,2Acylation of palmitic acid to proteins facilitates anchoring of membrane-bound proteins to the lipid bilayer and trafficking of intracellula... | |||
T76655 |
Prokineticin 2 Isoform 2 (human)
|
||
Prokineticin 2 Isoform 2 (human) 为一下丘脑神经肽,能减少食物摄入,并在啮齿动物的体温调节与能量代谢中发挥作用。此外,Prokineticin 2 对高血糖、代谢综合征 (MetS) 及肥胖研究具有潜在价值。 | |||
T62220 |
DGAT1-IN-3
|
||
DGAT1-IN-3 是一种选择性的、有效的,口服具有活力的 DGAT-1 抑制剂,能够抑制人类 DGAT-1 (IC50: 38 nM) 和大鼠 DGAT-1 (IC50: 120 nM)。DGAT1-IN-3 能够用于肥胖、血脂异常和代谢综合征的研究。 | |||
T63117 |
AMPK activator 7
|
||
AMPK activator 7 (compound I-3-24) 是一种 AMPK 激活剂 (EC50: 8.8 nM)。AMPK activator 7 能够用于涉及 AMPK 疾病的研究,尤其是 2 型糖尿病、高血糖症、代谢综合征、肥胖症、高胆固醇血症和/或高血压等疾病。 | |||
T36142 |
10-PAHSA
|
||
10-PAHSA is a newly identified endogenous lipid that belongs to a collection of branched fatty acid esters of hydroxy fatty acids (FAHFAs). It is a FAHFA in which palmitic acid is esterified to 10-hydroxy stearic acid. Among the FAHFA family members, PAHSAs are the most abundant in the adipose tissue of glucose tolerant AG4OX mice, which overexpress the Glut4 glucose transporter specifically in adipose tissue. As other FAHFAs improve glucose tolerance, stimulate insulin secretion, and have anti-... | |||
T79678 | PPARγ-IN-2 | PPAR | DNA Damage/DNA Repair; Metabolism |
PPARγ-IN-2 (Compound 5a) 是一款PPARγ抑制剂,可在3T3-L1前脂肪细胞中抑制TG积累,EC50值为0.106 μM。该化合物能够减轻HFC诱导的肥胖及相关代谢综合症状,同时降低脂肪组织内脂质的堆积。 | |||
T62052 |
AMPK activator 6
|
||
AMPK activator 6 (Compound GC) 可降低 HepG2 和 3T3-L1 细胞中的脂质含量并激活AMPK 通路。AMPK activator 6 对血清中甘油三酯 (TG)、总胆固醇 (TC)、低密度脂蛋白-C (LDL-C) 和其他生化指标的增加有显著的抑制作用。AMPK activator 6 在非酒精性脂肪肝(NAFLD)和代谢综合征中有研究价值。 | |||
T36760 | KQMEEEAVRLFIEWLKNGGPSSGAPPPS | ||
KQMEEEAVRLFIEWLKNGGPSSGAPPPS is a Exendin-4 peptide derivative. Exendin-4 is a pure GLP-1 receptor agonist. Exendin-4 peptide derivatives are structurally derived from Exendin-4 and may relates to dual GLP-1/glucagon receptor agonists. Their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake. These dual GLP-1/glucagon receptor agonists show reduced activity on the GIP receptor to reduce ... | |||
T37631 |
tetranor-12(S)-HETE
|
||
12(S)-HETE is a product of arachidonic acid metabolism through the 12-lipoxygenase pathway. It is primarily found in platelets, leukocytes, and to a lesser extent in smooth muscle cells. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix. tetranor-12(S)-HETE is the major β-oxidation product resulting from peroxisomal metabolism of 12(S)-HETE in numerous tissues, and Lewis lung carcinoma cells. No biological function has yet been determined for tetran... | |||
T13421 |
(-)-Cevimeline hydrochloride hemihydrate
(-)-SNI-2011,(-)-AF102B hydrochloride hemihydrate |
ALK | Angiogenesis; Tyrosine Kinase/Adaptors |
(-)-Cevimeline hydrochloride hemihydrate ((-)-SNI-2011) 是一种新型mAChR 激动剂,是一种治疗干燥综合征口干症的候选治疗药物。 | |||
T13460 |
(+)-Cevimeline hydrochloride hemihydrate
(+)-AF102B hydrochloride hemihydrate,(+)-SNI-2011 |
Others | Others |
(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011) 是一种有效的 mAChR 激动剂。 | |||
T38214 |
1-Deoxysphingosine (m18:1(4E))
1-Deoxysphingosine (m18:1(4E)) |
||
1-Deoxysphingosine (m18:1(4E)) is an atypical sphingolipid that contains a double bond at the 4E native position and is formed when serine palmitoyltransferase condenses palmitoyl-CoA with alanine instead of serine during sphingolipid synthesis.1,2 Plasma levels of 1-deoxysphingosine (m18:1(4E)) are increased in patients with chronic idiopathic axonal neuropathy (CIAP) and diabetic distal symmetrical polyneuropathy (DSPN).3 |1. Steiner, R., Saied, E.M., Othman, A., et al. Elucidating the chemica... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2S0271 |
Voacamine
老刺木胺,Voacanginine |
Cannabinoid Receptor; P-gp | GPCR/G Protein; Membrane transporter/Ion channel; Neuroscience |
Voacamine (Voacanginine) 是非洲马铃果中的一种吲哚生物碱,可抑制多药耐药肿瘤细胞中的 P-糖蛋白作用,具有强效的大麻素 CB1受体拮抗活性。 | |||
T2869 |
Emodin
Frangula emodin,大黄素 |
SARS-CoV; Casein Kinase; Autophagy | Autophagy; Metabolism; Microbiology/Virology; Stem Cells |
Emodin (Frangula emodin) 是蒽醌衍生物,有抗SARS-CoV 作用。它阻断 SARS 冠状病毒刺突蛋白和血管紧张素转化酶 2 的相互作用。它抑制酪蛋白激酶 2 ,具有抗炎和抗癌作用。它可改善饮食诱导的肥胖小鼠的代谢紊乱。 | |||
TN1475 |
Caulophyllogenin
Segetalic acid |
IL Receptor; TNF; PPAR; Immunology/Inflammation related | Apoptosis; DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism |
Caulophyllogenin 是一种部分 PPARγ 激动剂 (EC50 = 12.6 μM),来源于 Kalopanax pictus (五加科) 的茎皮。 Caulophyllogenin 抑制促炎细胞因子分泌,可用于预防和治疗炎症性疾病、2 型糖尿病、肥胖和代谢综合征的研究。 | |||
T4S1637 |
gamma-Mangostin
Normangostin,γ-倒捻子素 |
Others; 5-HT Receptor | GPCR/G Protein; Neuroscience; Others |
gamma-Mangostin (Normangostin) 是从药用植物山竹的果壳中提纯的一种天然产物,是一种竞争性5-HT2A 受体拮抗剂。它是运甲状腺素蛋白原纤维化抑制剂,与甲状腺素结合位点结合并稳定了 TTR 四聚体,具有抗高血压、预防结肠癌等作用。 | |||
T3794 |
Pentagalloylglucose
Penta-O-galloyl-β-D-glucose,1,2,3,4,6-O-Pentagalloylglucose,1,2,3,4,6-Penta-O-galloyl-beta-D-glucopyranose,1,2,3,4,6-五没食子酰葡萄糖 |
Influenza Virus | Microbiology/Virology |
1,2,3,4,6-O-Pentagalloylglucose (Penta-O-galloyl-β-D-glucose) 存在于多种植物中,具有重要的药理作用。Pentagalloylglucose 表现出显著的抗狂犬病病毒 (RABV) 活性。 | |||
TN5013 | Shizukaol D | AMPK | Chromatin/Epigenetic; PI3K/Akt/mTOR signaling |
Shizukaol D exerts a growth inhibition effect on liver cancer cells in a dose- and time-dependent manner by modulating wnt signalling pathway. Shizukaol D may be used to treat metabolic syndrome, it induces mitochondrial dysfunction by depolarizing the mitochondrial membrane and suppressing energy production, which may result in AMPK activation. | |||
TN4670 |
Norlichexanthone
|
Antibacterial; Parasite | Microbiology/Virology |
Norlichexanthone 具有治疗和/或预防生活方式相关疾病的潜力,例如 2 型糖尿病、代谢综合征、动脉粥样硬化和心血管疾病。 它具有抗菌和抗疟活性,对枯草芽孢杆菌有很强的活性,IC50范围为1-5uM,对耐甲氧西林金黄色葡萄球菌的生长也有很强的抑制作用,IC50为20.95±1.56uM。 | |||
T83915 |
Norbixin hydrate
|
||
Norbixin是一种在B. orellana中发现的类胡萝卜素,具有多样的生物活性。在无细胞测试中,它与过氧化物酶体增殖物激活受体γ (PPARγ)结合(Ki = 1.15 µM)。在心脑血管代谢综合征大鼠模型中,Norbixin (47.7 mg/kg) 能够减轻高血糖、高胰岛素血症和胰岛素抗性,降低血清脂质水平及心脏中硫代巴比妥酸反应性物质(TBARS)和谷胱甘肽(GSH)的水平。在胆固醇诱导的动脉粥样硬化兔模型中,它降低氧化型LDL和主动脉蛋白氧化水平,并减少动脉粥样硬化面积。Norbixin(每天0.1和1 mg/kg)减少汞诱导的大鼠肝细胞和白细胞DNA损伤。此外,它还能预防与年龄相关的黄斑变性(AMD)Abca4-/- Rdh8-/-小鼠模型中的光感受器退化。 |